The global Vacuum Blood Collection Tube Market size is projected to reach USD 3.20 billion by 2030, registering a CAGR of 3.02% during the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic and infectious diseases, a growing number of blood transfusions, coupled with rising hematological disorders are boosting the adoption of blood collection tubes. In addition, frequent disease outbreaks in endemic areas are anticipated to increase the demand for blood collection tubes for clinical diagnostics. The market is anticipated to witness rapid growth owing to the factors, such as the growing need for the identification of infectious agents, cancer biomarkers, cardiovascular diseases, women’s health issues, and substance abuse.
A
blood test is performed for numerous indications, such as infection, anemia,
hypokalemia, leukemia, and kidney function. Lab diagnostics, relying on
diagnostic tests to commence the treatment of any disease condition, has played
a substantial role in the demand growth of the tubes. In addition, contagious
diseases have made the most important impact on any cause of hospital
admissions. Currently, emerging and re-emerging infectious diseases are
presenting public health danger. For instance, as per the WHO, almost 1.2
million people in the U.S. have HIV. Vacuum tubes are used routinely for the
collection of blood specimens in laboratory diagnostics, globally. They have numerous
advantages over the traditional method of drawing blood with the use of
syringes as the closed vacuum tube assures phlebotomist safety and clean
specimens due to minimal transferring and touching.
They
are safer and easier to use and come with pre-added additives. The stopper's
color coding is common, which makes it effortless to communicate and understand
the medical community. Moreover, it also permits many tubes to be filled in one
sitting; thereby lowering the chance of hemolysis. Vacutainers have other
advantages as well, such as increased proficiency in diagnostic tests,
shortened time of blood draws, and reduced needlestick injuries & risk of
contamination. The COVID-19 pandemic has had a positive impact on industry
growth owing to the increased government support for exploring the
possibilities of allowing laboratories to enhance the blood testing process.
However, since the beginning of the pandemic, the healthcare industry has been
facing several challenges.
Currently,
BD’s specimen management business is challenged by a high demand for blood
collection tubes, further challenging the company’s capability to supply
products and achieve necessary raw materials for its manufacturing plants.
However, leading players expanded their manufacturing capabilities to fulfill
the global demand for vacutainers during the pandemic. For instance, as of May
2022, BD announced that the supply of Vacutainer Citrate Tubes has been
stabilized and is no longer on manual allocation or backorder. Furthermore, as per
the data provided by the WHO, around 118.5 million units of donated blood are
collected worldwide each year. From 2008 to 2018, an increase of 10.7 million
blood donations from voluntary unpaid donors has been reported.
Thus,
the rise in donations will increase the usage of the collection tubes; thereby
accelerating the industry growth over the forecast period. However, the
shortage of skilled personnel and lack of product awareness in low- and
middle-income economies might hamper the industry growth. The growing aging
population and experienced operators retiring without being replaced by lab
technicians of the new generation are at the core, globally. Moreover, in 2022,
a medical laboratory workforce study conducted by the University of Washington
Center for Health Workforce Studies and ASCP found that challenges in the
laboratory field comprise a shortage of qualified personnel, a falling number
of accredited education programs, and increased demands due to vacancy rates
and testing volumes.
Related Press
Release@ Vacuum
Blood Collection Tube Market Report
Vacuum Blood Collection Tube Market Report Highlights
- The
serum-separating tube segment accounted for the largest share in 2022.
These tubes have gained wide acceptance due to the benefit of the barrier
gel that enables rapid separation of serum from cellular constituents of
blood and thus lessens the hemolysis
- The
PET/plastic material segment accounted for the largest share in 2022.
Compared to glass, plastic decreases the exposure to biohazardous material
following breakage, endures higher centrifugation speeds, has a greater
shock resistance, weighs less, and is more effortlessly disposed of by
incineration at a lower cost
- The blood
routine examination application segment dominated the industry in 2022 owing
to the factors, such as the prevalence of lifestyle diseases and the rise
in awareness about routine examination
- The
pathology laboratories end-use segment led the industry in 2022 due to the
high prevalence of various diseases, such as hepatitis B, HIV AIDS,
diabetes, cancer, and heart diseases, which require various blood tests to
confirm the extremity of the disease
- North
America was the largest region in 2022 due to the presence of leading
clinical diagnostics companies & well-developed healthcare infrastructure
and a high number of R&D activities
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment